<DOC>
	<DOCNO>NCT00761891</DOCNO>
	<brief_summary>The purpose study obtain reference range newly develop assay ex vivo platelet COX-1 activity normal volunteer take routine clinical dose aspirin .</brief_summary>
	<brief_title>Validation Assay Measure Cyclooxygenase-1 Activity</brief_title>
	<detailed_description>Aspirin show reduce cardiovascular event at-risk individual , aspirin-treated patient fail exhibit expect change bleed time platelet aggregation . Recent evidence correlate aspirin `` non-response '' poor cardiovascular outcome . In order study mechanisms aspirin resistance , assay need measure catalytic activity platelet cyclooxygenase ( inhibited aspirin ) . A common assay general use measurement thromboxane B2 production clot whole blood . This measure , however , influence genetic environmental variation glass-activated coagulation pathway , albumin binding capacity , platelet activation pathway , arachidonic acid pool , phospholipase activity . Our laboratory develop direct assay platelet cyclooxygenase ( COX-1 ) activity influenced variation . This study generate reference range normal volunteer take routine clinical dose aspirin ( 81mg daily ) assay . In addition , use two aspirin formulation ( enteric-coated chewable ) , study design additionally allow secondary comparison effect two formulation COX-1 inhibition .</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Nonsmoker No chronic medical illness No chronic medication Aspirin/NSAID use precede 14 day History chronic NSAID use Currently take NSAIDs , opioid analgesic , corticosteroid , anticoagulant History coronary artery disease , myocardial infarction , coronary artery bypass grafting , percutaneous angioplasty , diabetes mellitus , stroke . History hypertension Body mass index &gt; 35 History gastric , duodenal , esophageal ulcer serious gastrointestinal bleed History frequent headache , pain syndrome , condition require frequent use analgesic History adverse reaction aspirin Screening platelet count &lt; 100,000/ul &gt; 500,000/ul Screening hematocrit &lt; 35 % &gt; 50 % Weight le 110 pound Pregnant female</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>aspirin</keyword>
	<keyword>cyclooxygenase-1</keyword>
	<keyword>aspirin resistance</keyword>
	<keyword>aspirin nonresponse</keyword>
	<keyword>platelet</keyword>
	<keyword>Normal volunteer</keyword>
</DOC>